OPK
Price
$0.99
Change
-$0.01 (-1.00%)
Updated
Mar 1, 6:59 PM EST
63 days until earnings call
XAIR
Price
$1.98
Change
-$0.07 (-3.41%)
Updated
Mar 1, 6:59 PM EST
109 days until earnings call
Ad is loading...

OPK vs XAIR ᐉ Comparison: Which is Better to Invest?

Header iconOPK vs XAIR Comparison
Open Charts OPK vs XAIRBanner chart's image
OPKO Health
Price$0.99
Change-$0.01 (-1.00%)
Volume$6.35M
CapitalizationN/A
Beyond Air
Price$1.98
Change-$0.07 (-3.41%)
Volume$183.32K
CapitalizationN/A
View a ticker or compare two or three
OPK vs XAIR Comparison Chart

Loading...

OPKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
XAIRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
OPK vs. XAIR commentary
Mar 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OPK is a Hold and XAIR is a StrongSell.

COMPARISON
Comparison
Mar 04, 2024
Stock price -- (OPK: $0.99 vs. XAIR: $1.98)
Brand notoriety: OPK and XAIR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: OPK: 57% vs. XAIR: 74%
Market capitalization -- OPK: $692.04M vs. XAIR: $71.36M
OPK [@Medical Specialties] is valued at $692.04M. XAIR’s [@Medical Specialties] market capitalization is $71.36M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OPK’s FA Score shows that 0 FA rating(s) are green whileXAIR’s FA Score has 0 green FA rating(s).

  • OPK’s FA Score: 0 green, 5 red.
  • XAIR’s FA Score: 0 green, 5 red.
According to our system of comparison, XAIR is a better buy in the long-term than OPK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OPK’s TA Score shows that 3 TA indicator(s) are bullish while XAIR’s TA Score has 5 bullish TA indicator(s).

  • OPK’s TA Score: 3 bullish, 2 bearish.
  • XAIR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, OPK is a better buy in the short-term than XAIR.

Price Growth

OPK (@Medical Specialties) experienced а +4.96% price change this week, while XAIR (@Medical Specialties) price change was +13.14% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.37%. For the same industry, the average monthly price growth was +3.60%, and the average quarterly price growth was -0.02%.

Reported Earning Dates

OPK is expected to report earnings on May 06, 2024.

XAIR is expected to report earnings on Jun 21, 2024.

Industries' Descriptions

@Medical Specialties (+2.37% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for OPK with price predictions.
OPEN
A.I.dvisor published
a Summary for XAIR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
OPK($692M) has a higher market cap than XAIR($71.4M). XAIR YTD gains are higher at: 1.020 vs. OPK (-34.245). OPK (-65.52M) and XAIR (-67.06M) have comparable annual earnings (EBITDA) . OPK has more cash in the bank: 95.9M vs. XAIR (31.3M). XAIR has less debt than OPK: XAIR (16.9M) vs OPK (327M). OPK has higher revenues than XAIR: OPK (863M) vs XAIR (689K).
OPKXAIROPK / XAIR
Capitalization692M71.4M969%
EBITDA-65.52M-67.06M98%
Gain YTD-34.2451.020-3,356%
P/E Ratio26.11N/A-
Revenue863M689K125,254%
Total Cash95.9M31.3M306%
Total Debt327M16.9M1,935%
FUNDAMENTALS RATINGS
OPK vs XAIR: Fundamental Ratings
OPK
XAIR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
44
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9399
PRICE GROWTH RATING
1..100
8758
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
5048

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XAIR's Valuation (44) in the null industry is in the same range as OPK (65) in the Biotechnology industry. This means that XAIR’s stock grew similarly to OPK’s over the last 12 months.

XAIR's Profit vs Risk Rating (100) in the null industry is in the same range as OPK (100) in the Biotechnology industry. This means that XAIR’s stock grew similarly to OPK’s over the last 12 months.

OPK's SMR Rating (93) in the Biotechnology industry is in the same range as XAIR (99) in the null industry. This means that OPK’s stock grew similarly to XAIR’s over the last 12 months.

XAIR's Price Growth Rating (58) in the null industry is in the same range as OPK (87) in the Biotechnology industry. This means that XAIR’s stock grew similarly to OPK’s over the last 12 months.

OPK's P/E Growth Rating (96) in the Biotechnology industry is in the same range as XAIR (100) in the null industry. This means that OPK’s stock grew similarly to XAIR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OPKXAIR
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
73%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
78%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
84%
Bearish Trend 4 days ago
85%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Ad is loading...
OPKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
XAIRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDIIX15.620.18
+1.17%
iShares MSCI EAFE Intl Idx Inv A
BAILX10.780.07
+0.65%
Brown Advisory Sustainable Intl Ldrs Ins
RPMIX9.460.06
+0.64%
Royce Pennsylvania Mutual Instl
HWAAX36.860.19
+0.52%
Hotchkis & Wiley Value Opps A
DEVDX12.400.02
+0.16%
Driehaus Event Driven

XAIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XAIR has been loosely correlated with PSNL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if XAIR jumps, then PSNL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XAIR
1D Price
Change %
XAIR100%
-3.41%
PSNL - XAIR
40%
Loosely correlated
+9.03%
RBOT - XAIR
35%
Loosely correlated
-13.97%
OPK - XAIR
35%
Loosely correlated
-0.71%
KIDS - XAIR
32%
Poorly correlated
+2.22%
CERS - XAIR
31%
Poorly correlated
N/A
More